Co-Authors
This is a "connection" page, showing publications co-authored by Arthur Kim and Raymond Chung.
Connection Strength
0.940
-
Liver Biochemistries in Hospitalized Patients With COVID-19. Hepatology. 2021 03; 73(3):890-900.
Score: 0.228
-
Direct-Acting Antiviral Therapy for Chronic HCV Infection Results in Liver Stiffness Regression Over 12 Months Post-treatment. Dig Dis Sci. 2018 02; 63(2):486-492.
Score: 0.183
-
Effect of Sofosbuvir-Based Hepatitis C Virus Therapy on Kidney Function in Patients with CKD. Clin J Am Soc Nephrol. 2017 Oct 06; 12(10):1615-1623.
Score: 0.183
-
Phenotype and function of HBV-specific T cells is determined by the targeted epitope in addition to the stage of infection. Gut. 2019 05; 68(5):893-904.
Score: 0.050
-
Effects of sofosbuvir-based hepatitis C treatment on the pharmacokinetics of tenofovir in HIV/HCV-coinfected individuals receiving tenofovir disoproxil fumarate. J Antimicrob Chemother. 2018 08 01; 73(8):2112-2119.
Score: 0.049
-
IDSA/AASLD Response to Cochrane Review on Direct-Acting Antivirals for Hepatitis C. Clin Infect Dis. 2017 11 13; 65(11):1773-1775.
Score: 0.046
-
Early Transcriptional Divergence Marks Virus-Specific Primary Human CD8+ T Cells in Chronic versus Acute Infection. Immunity. 2017 10 17; 47(4):648-663.e8.
Score: 0.046
-
Benefits of Direct-Acting Antivirals for Hepatitis C. Ann Intern Med. 2017 Dec 05; 167(11):812-813.
Score: 0.046
-
Comments on cochrane review on direct-acting antivirals for hepatitis C. Hepatology. 2017 10; 66(4):1016-1019.
Score: 0.046
-
Sofosbuvir Plus Ribavirin Without Interferon for Treatment of Acute Hepatitis C Virus Infection in HIV-1-Infected Individuals: SWIFT-C. Clin Infect Dis. 2017 04 15; 64(8):1035-1042.
Score: 0.045
-
High resolution analysis of cellular immune responses in resolved and persistent hepatitis C virus infection. Gastroenterology. 2004 Sep; 127(3):924-36.
Score: 0.019